We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-10 of 15

Mobile health apps: are they a regulated medical device?
  • White & Case LLP
  • European Union
  • August 12 2015

With the proliferation of smartphones, the market for mobile applications (apps) has developed very rapidly in recent years, becoming a key driver of

Securing patent value for Israeli medical technology companies
  • White & Case LLP
  • Israel
  • August 7 2013

Israel is a leader in medical technology and life sciences innovation. Though the life sciences industry in Israel is young, it is growing fast: in

China renames regulatory agency: what’s in store for the cosmetics and medical device industries?
  • White & Case LLP
  • China
  • June 5 2013

In March 2013, the National People's Congress of China formally changed the name of the State Food and Drug Administration (SFDA) to the China Food

FDA posts recommendations for expediting imports of medical devices
  • White & Case LLP
  • USA
  • May 16 2011

On 24 March 2011, the FDA posted on its website certain recommendations to the medical devices industry for the purpose of expediting the admissibility process of imported medical devices into the United States.

Spectranetics settles with DOJ over illegally imported medical devices
  • White & Case LLP
  • USA
  • February 2 2010

On December 30, 2009, the US Department of Justice (DOJ) announced a settlement with medical laser manufacturer, Spectranetics Corp. (Spectranetics), over allegations that the company illegally imported and sold medical devices for patient use that had not been approved by the FDA.

An important reminder of the value of DOJ FCPA opinion procedure as FCPA enforcement efforts continue to rise
  • White & Case LLP
  • USA
  • August 14 2009

On August 3, 2009, the US Department of Justice ("DOJ") issued its first official Foreign Corrupt Practices Act ("FCPA") guidance in more than a year.

DOJ and SEC officials discuss emerging trends in FCPA enforcement; Supreme Court leaves expansive coverage decision intact
  • White & Case LLP
  • USA
  • October 21 2008

Two recent developments highlight the broad reach of the U.S. Foreign Corrupt Practices Act (“FCPA”).

US medical device company agrees to pay fine and engage independent corporate monitor
  • White & Case LLP
  • USA
  • June 5 2008

AGA Medical Corporation, a US medical device company, has agreed to pay a $2 million criminal fine in connection with corrupt payments to Chinese doctors from 1997 through 2005.

Jacquelyn MacLennan
  • White & Case LLP